Researchers from all over the world have formulated tests, taking diagnostics to a new high.
World Congress of Cardiology, Barcelona, witnessed the presentation of a novel device that can monitor heart patients at home. Dubbed the ‘smart shirt’, it incorporates stainless steel threads that can record an electrocardiogram and transmit it over the mobile phone network to a central monitoring center. Tests have confirmed it is as reliable as electrocardiogram machines used in hospitals.
At another conference, the 23rd International Papillomavirus Congress and Clinical Workshop, Innogenetics announced its entry into the field of diagnostics with a test for human papillomavirus. The Belgian pharmaceuticals company has developed a test to diagnose HPV genotypes including 6, 11, 16, and 18. The test, called INNO-LiPA HPV Genotyping CE will be a complement to other tests like Pap smear and DNA-based HPV screening tests. The test will also aid the selection of individuals eligible for HPV vaccination. Formal CE-marking of the test is expected by October.
Meanwhile, researchers from the University of Arkansas for Medical Sciences and the Arkansas Children's Hospital Research Institute have formulated a new test to detect acetaminophen poisoning in both children and adults. The test centers around a protein compound called cysteine adducts that forms with toxic doses of acetaminophen. In a study conducted to determine its effectiveness, the test identified potential acetaminophen toxicity in eight of 64 samples from patients with liver damage of undetermined cause.
Another simple test has been developed in Niger to detect meningococcal meningitis. Two paper strips called ‘dipsticks’ dipped in the patient's spinal fluid can indicate whether one of the four groups of meningococcus is present, and if so, which one. The test is ideal for healthcare workers in remote areas as it requires neither sophisticated laboratory equipment nor refrigeration.
Powered by Qumana